BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25132000)

  • 41. [Dermatological stigmata in Rubinstein-Taybi syndrome].
    Harth W; Linse R
    Hautarzt; 2001 Oct; 52(10 Pt 2):977-9. PubMed ID: 11715398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronologic change of the maximum dimension of Bacillus Calmette-Guerin-induced keloids.
    Tosa M; Murakami M; Ghazizadeh M; Hyakusoku H
    Dermatol Surg; 2009 Feb; 35(2):189-94. PubMed ID: 19215254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral and dental manifestations in Rubinstein-Taybi syndrome: report of a rare case.
    Gunashekhar M; Hameed MS; Bokhari SK
    Prim Dent Care; 2012 Jan; 19(1):35-8. PubMed ID: 22244492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exome Sequencing Identification of EP300 Mutation in a Proband with Coloboma and Imperforate Anus: Possible Expansion of the Phenotypic Spectrum of Rubinstein-Taybi Syndrome.
    Masuda K; Akiyama K; Arakawa M; Nishi E; Kitazawa N; Higuchi T; Katou Y; Shirahige K; Izumi K
    Mol Syndromol; 2015 Jul; 6(2):99-103. PubMed ID: 26279656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of vascular endothelial growth factor in keloids: a clinicopathologic study.
    Salem A; Assaf M; Helmy A; Nofal A; Ibrahim S; Eldeeb F; Youssef C
    Int J Dermatol; 2009 Oct; 48(10):1071-7. PubMed ID: 19775400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of upper torso stress amplification, tissue compression and distortion in the pathogenesis of keloids.
    Bux S; Madaree A
    Med Hypotheses; 2012 Mar; 78(3):356-63. PubMed ID: 22230168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cephalometric study in Rubinstein-Taybi syndrome.
    Hennekam RC; Van den Boogaard MJ; Van Doorne JM
    J Craniofac Genet Dev Biol; 1991; 11(1):33-40. PubMed ID: 2061404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Keloids: a review.
    Murray JC; Pollack SV; Pinnell SR
    J Am Acad Dermatol; 1981 Apr; 4(4):461-70. PubMed ID: 7014664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors.
    Viani GA; Stefano EJ; Afonso SL; De Fendi LI
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1510-6. PubMed ID: 19101094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early postoperative magnet application combined with hydrocolloid dressing for the treatment of earlobe keloids.
    Park TH; Chang CH
    Aesthetic Plast Surg; 2013 Apr; 37(2):439-44. PubMed ID: 23377145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Keloids: an update on medical and surgical treatments.
    Love PB; Kundu RV
    J Drugs Dermatol; 2013 Apr; 12(4):403-9. PubMed ID: 23652887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Keloids.
    Doyle-Lloyd DJ; White JA
    J La State Med Soc; 1991 Dec; 143(12):9-12. PubMed ID: 1779193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of keloid formation in humans and laboratory animals.
    Khorshid FA
    Med Sci Monit; 2005 Jul; 11(7):BR212-9. PubMed ID: 15990682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral and cephalometric study in Brazilian Rubinstein-Taybi syndrome patients.
    Martins F; Roussen AC; Rezende N; Hiraoka C; Zamunaro M; Gallottini M
    Spec Care Dentist; 2022 Mar; 42(2):143-148. PubMed ID: 34590347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneous Features of Keloids Assessed by Laser Speckle Contrast Imaging: A Cross-Sectional Study.
    Chen C; Zhang M; Yu N; Zhang W; Long X; Wang Y; Wang X
    Lasers Surg Med; 2021 Aug; 53(6):865-871. PubMed ID: 33027537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scars and keloids.
    Murray JC
    Dermatol Clin; 1993 Oct; 11(4):697-708. PubMed ID: 8222353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Keloids: an unwanted spontaneity in rubinstein-taybi syndrome.
    Shilpashree P; Jaiswal AK; Kharge PM
    Indian J Dermatol; 2015; 60(2):214. PubMed ID: 25814745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac abnormalities in the Rubinstein-Taybi syndrome.
    Stevens CA; Bhakta MG
    Am J Med Genet; 1995 Nov; 59(3):346-8. PubMed ID: 8599359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of the 300 microsecond 1064 nm Nd:YAG laser in the treatment of keloids.
    Rossi A; Lu R; Frey MK; Kubota T; Smith LA; Perez M
    J Drugs Dermatol; 2013 Nov; 12(11):1256-62. PubMed ID: 24196333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors of keloids in Syrians.
    Shaheen A; Khaddam J; Kesh F
    BMC Dermatol; 2016 Sep; 16(1):13. PubMed ID: 27646558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.